Top news of the day across the health care landscape.
HIV advocates suggest that prevention campaigns should focus on reaching more black women with pre-exposure prophylaxis (PrEP), NPR reported. According to the article, Leisha McKinley-Beach, a national HIV/AIDS consultant, said that the “unequal roll-out of PrEP to women” should be resolved in the Trump administration’s new plan to eradicate HIV. Black women make up 62% of all new HIV diagnoses among women, but knowledge about PrEP among women, particularly for black and Latina women, is low, the article reported.
Johnson & Johnson announced it would start disclosing list prices of its prescription drugs in television ads, The Associated Press reported. According to the article, the company will begin with its medication Xarelto and will provide the pill’s list price plus typical out-of-pocket costs in the commercial. Johnson & Johnson will be the first drug manufacturer to include its list prices in its TV ads, the article reported.
The FDA is cracking down on Walgreens after finding that 22% of the 6350 stores it has inspected sold tobacco products to minors, The Hill reported. According to the article, the agency is putting the pharmacy chain on notice and FDA Commissioner Scott Gottlieb, MD, has requested a meeting with Walgreens’ corporate management to warn them about additional enforcement avenues. A Walgreens spokesman said in a statement that the company is taking steps to address the problem, the article reported.